家庭氧疗包括COPD(国外英文资料).doc

家庭氧疗包括COPD(国外英文资料) Family oxygen therapy is one of the main factors affecting the prognosis of COPD. Due to the generation of new oxygen cure technology and oxygen cure method of continuous improvement, not only improve the effect of the oxygen cure, also use has brought great convenience to patients, to make long-term oxygen therapy applied more widely. Long-term oxygen therapy and the developed countries in Europe and the United States is relatively common, in Asia and some developing countries due to the limitation of social and economic development level, carry out less. Long-term oxygen therapy for COPD patients in our country, there is no exact statistics. To carry out long-term oxygen therapy is most common in the United States, the world leading position, every 100000, 241 people applied long-term oxygen therapy in patients with COPD. In the United States, the cost of household oxygen therapy was $1.1 billion in 1993 and $1.4 billion in 1994. Although oxygen cure cost increase, the statistical results show that if you dont use oxygen therapy, these patients the overall social burden will increase due to the case fatality rate, lower quality of life and individual production efficiency to reduce significantly increased all the more. 1 long-term oxygen therapy of chronic respiratory failure indications 1.1 stability after quitting smoking, chest physical therapy and drug therapy stable state of patients with COPD, resting state arterial hypoxemia, namely the breathing indoor air, the arterial blood oxygen partial pressure (PaO2) 7.3 kPa (55 MMHG) or arterial blood oxygen saturation (SaO2) 0.88. This is the most important indications of long-term oxygen therapy. Patients with COPD have a PaO2 of 7.3-8.7 kPa (55-65mmhg), accompanied by one of the following conditions, and long-term oxygen treatment. Secondary erythropoiosis (red blood cell deposit, 0.55); The clinical manifestations of pulmonary disease; The pulmonary hypertension. 1.2 hypoxemia waking sleep